NHS to pilot 'potentially revolutionary' cancer blood test

Developed by GRAIL

Adam Saville
clock
NHS to pilot 'potentially revolutionary' cancer blood test

The 'Galleri blood test' aims to detect cancers early by looking for abnormal DNA

The NHS is to trial a ‘potentially revolutionary' blood test that could discover a range of different cancer types is to be trialled by the NHS, the national health service's chief executive Sir Simon Stevens has announced. Known as the Galleri blood test, it has been developed by the company GRAIL to spot early signs of cancer by seeking out abnormal DNA shed from cells into the blood. DNA from cancer cells often have differences in the chemical tags compared to DNA from healthy cells. The...

To continue reading this article...

Join Cover

  • Unlimited access to real-time news, key trend analysis and industry insights.
  • Stay on top of the latest developments around Covid-19, regulation, diversity and mental health.
  • Receive breaking news stories straight to your inbox in the daily newsletter.
  • Exclusive access to our fortnightly Protection insight mini-podcast.
  • Be the first to hear about our CPD accredited events and awards programmes.

Join now

 

Already a Cover member?

Login

More on Individual Protection

COVER Blue Monday webinar now available on demand

COVER Blue Monday webinar now available on demand

The whole wellbeing proposition

COVER
clock 20 January 2022 • 1 min read
Jo Throp: Neurological conditions require a specialist approach

Jo Throp: Neurological conditions require a specialist approach

"The protection industry needs to consider more deeply the cost and impact of neurological claims"

John Brazier
clock 18 January 2022 • 8 min read
Royal London extends Helping Hand wellbeing services

Royal London extends Helping Hand wellbeing services

Includes GP consultations and mental wellbeing app

John Brazier
clock 17 January 2022 • 1 min read